MATTHEW OSENBAUGH: Open Payments
NPI 1649587593 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,207 in 125 payments from 17 companies in 2025. Trend: 2023 $2,627 · 2024 $1,897 · 2025 $2,207
Food & beverage: $2,130Education: $77
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $408 |
| ABBVIE INC. | 35 | $399 |
| Janssen Biotech, Inc. | 13 | $307 |
| Lilly USA, LLC | 11 | $291 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $176 |
| Aimmune Therapeutics, Inc. | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Madrigal Pharmaceuticals | 5 | $81 |
| Ipsen Biopharmaceuticals, Inc | 4 | $77 |
| Ardelyx, Inc. | 4 | $63 |
Products named: ENTYVIO, TREMFYA, OMVOH, XIFAXAN, DUPIXENT, ZENPEP, LINZESS, SKYRIZI.
Industry payments across KS — which companies pay providers there.
